Adamantane-like aluminum amide-phosphate from alumazene

Pharmacological profile of natural and synthetic compounds with rigid adamantane-based scaffolds as potential agents for the treatment of neurodegenerative diseases

This review is dedicated to the comparative analysis of structure-activity relationships for more than 75 natural and synthetic derivatives of adamantane. Some of these compounds, such as amantadine and memantine, are currently used to treat dementia, Alzheimer's and Parkinson's diseases and other neurodegenerative diseases. The data presented show that the pharmacological potential of 1-fluoro- and 1-phosphonic acid adamantane derivatives against Alzheimer's and Parkinson's diseases and other neurodegenerative diseases exceeds those of well-known amantadine and memantine. The information presented in this review highlights the promising directions of studies for biochemists, pharmacologists, medicinal chemists, physiologists, and neurologists, as well as to the pharmaceutical industry.

Alumazene Adducts with Pyridines: Synthesis, Structure, and Stability Studies

Lewis acid-base adducts of the alumazene [2,6-(i-Pr)2C6H3NAlMe]3 (1) with pyridine (py) and 4-dimethylaminopyridine (dmap) were synthesized and structurally characterized: 1(py)2 (2), 1(py)3 (3), 1(dmap)2 (4), and 1(py)(dmap) (5). The bisadducts 2, 4, and 5 form the trans isomers. The trisadduct 3 exhibits an unexpected cis-cis isomer and can be prepared only in the presence of excess py. The planarity of the alumazene ring is lost upon coordination of the Lewis base molecules. A comparison of the Al-N(base) bond distances and pyramidality at Al suggests the higher basicity of dmap. NMR spectroscopy confirms stability to dissociation of the bisadducts in solution while the trisadduct 3 is labile and converts to 2. The thermodynamics of the adduct formation has been investigated experimentally and theoretically. Thermodynamic characteristics of the 1(py)n (n=2, 3) dissociation reactions in the temperature range 25-200 degrees C have been derived from the vapor pressure-temperature dependence measurements by the static tensimetric method. In all experiments, excess py was employed. Quantum chemical computations at the B3LYP/6-31G* level of theory have been performed for the 1(py)n and model complexes [HAlNH]3(py)n (n=1-3). Obtained results indicate that for the gas phase adducts upon increasing the number of py ligands the donor-acceptor Al-N(py) distance increases in accord with decreasing donor-acceptor bond dissociation energies.

Mononuclear Schiff Base Boron Halides: Synthesis, Characterization, and Dealkylation of Trimethyl Phosphate

A series of mononuclear boron halides of the type LBX(2) [LH = N-phenyl-3,5-di-tert-butylsalicylaldimine, X = Cl (2), Br (3)] and LBX [LH2 = N-(2-hydroxyphenyl)-3,5-di-tert-butylsalicylaldimine, X = Cl (7), Br (8); LH2 = N-(2-hydroxyethyl)-3,5-di-tert-butylsalicylaldimine, X = Cl (9), Br (10); and LH2 = N-(3-hydroxypropyl)-3,5-di-tert-butylsalicylaldimine, X = Cl (11), Br (12)] were synthesized from their borate precursors LB(OMe)2 (1) (LH = N-phenyl-3,5-di-tert-butylsalicylaldimine) and LB(OMe) [LH2 = N-(2-hydroxyphenyl)-3,5-di-tert-butylsalicylaldimine (4), N-(2-hydroxyethyl)-3,5-di-tert-butylsalicylaldimine (5), N-(3-hydroxypropyl)-3,5-di-tert-butylsalicylaldimine (6)]. The boron halide compounds were air and moisture sensitive, and upon hydrolysis, compound 7 resulted in the oxo-bridged compound 13 that contained two seven-membered boron heterocycles. The boron halide compounds dealkylated trimethyl phosphate in stoichiometric reactions to produce methyl halide and unidentified phosphate materials. Compounds 8 and 12 were found to be the most effective dealkylating agents. On reaction with tert-butyl diphenyl phosphinate, compound 8 produced a unique boron phosphinate compound LB(O)OPPh2 (14) containing a terminal phosphinate group. Compounds 1-14 were characterized by 1H, 13C, 11B, 31P NMR, IR, MS, EA, and MP. Compounds 5, 6, and 11-14 also were characterized by single-crystal X-ray diffraction.

A Supramolecular Hexameric Ring from Alumazene and Methylsulfonate

A dealkylsilylation reaction of alumazene [2,6-(i-Pr)2C6H3NAlMe]3 (1) with trimethylsilyl methylsulfonate in a 1:2 molar ratio in toluene afforded a supramolecular cyclic hexamer {Me[2,6-(i-Pr)2C6H3NAl]3(O3SMe)2}6 (2) composed of six intact alumazene rings and possessing two types of bridging sulfonate groups. Changing the reagent molar ratio to 1:3 caused the third sulfonate to partially substitute the last alumazene methyl group in an eta2 fashion and introduced a disorder in the crystal lattice.

Five-Coordinate Aluminum Bromides: Synthesis, Structure, Cation Formation, and Cleavage of Phosphate Ester Bonds

The alkane elimination reaction between Salen((t)Bu)H(2) ligands and diethylaluminum bromide was used to prepare three Salen aluminum bromide compounds salen((t)Bu)AlBr (1) (salen = N,N'-ethylenebis(3,5-di-tert-butylsalicylideneimine)), salpen((t)Bu)AlBr (2) (salpen = N,N'-propylenebis(3,5-di-tert-butylsalicylideneimine)), and salophen((t)Bu)AlBr (3) (salophen = N,N'-o-phenylenenebis(3,5-di-tert-butylsalicylideneimine)). The compounds contain five-coordinate aluminum either in a distorted square pyramidal or a trigonal bipyramidal environment. The bromide group in these compounds could be displaced by triphenylphosphine oxide or triphenyl phosphate to produce the six-coordinate cationic aluminum compounds [salen((t)Bu)Al(Ph(3)PO)(2)]Br (4), [salpen((t)Bu)Al(Ph(3)PO)(2)]Br (5), [salophen((t)Bu)Al(Ph(3)PO)(2)]Br (6), and [salophen((t)Bu)Al[(PhO)(3)PO)](2)]Br (7). All the compounds were characterized by (1)H, (13)C, (27)Al, and (31)P NMR, IR, mass spectrometry, and melting point. Furthermore, compounds 1-3 and 5-7 were structurally characterized by single-crystal X-ray diffraction. Compounds 1-3 dealkylated a series of organophosphates in stoichiometric reactions by breaking the ester C-O bond. Also, they were catalytic in the dealkylation reaction between trimethyl phosphate and added boron tribromide.